COMP <GO>
CNXU vs MYO // REVENUE GROWTH (YOY)
Conexeu Sciences Inc. (NASDAQ) VS. Myomo Inc. (NYSE) • 15-METRIC TALLY: CNXU 1
— MYO 1
■ METRIC PARITY
LAST: $2.83 (-1.74%) • MKT CAP: $85.8M
revenue-growth
—
LAST: $1.30 (+3.18%) • MKT CAP: $51.5M
revenue-growth
25.70%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNXU VS. MYO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNXU | MYO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 65.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -35.20% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -38.10% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) ACTIVE | — | 25.70% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 4/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 39.4 | 47.9 | -8.50 | MYO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $85.8M | $51.5M | $34.3M | CNXU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNXU REV | MYO REV | CNXU GROSS % | MYO GROSS % | CNXU FCF | MYO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $40.9M | — | 65.7% | — | -$16.3M |
| FY 2024 | — | $32.6M | — | 71.2% | — | -$4.7M |
| FY 2023 | — | $19.2M | — | — | — | -$6.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNXU // BETA —
MYO // BETA —